Kaplan-Meier estimates of overall survival (OS) for (A) High-volume total patient population, (B) Low-volume total patient population, (C) High-volume de novo metastatic patients, (D) Low-volume de novo metastatic patients, (E) High-volume patients with prior local therapy, (F) Low-volume patients with prior local therapy. HR, hazard ratio; NR, not reached.